Celsius Holdings, Inc. Stock

Equities

CELH

US15118V2079

Non-Alcoholic Beverages

Market Closed - Nasdaq 04:00:00 2024-04-19 pm EDT 5-day change 1st Jan Change
68.84 USD -1.61% Intraday chart for Celsius Holdings, Inc. -13.65% +26.27%
Sales 2024 * 1.88B Sales 2025 * 2.48B Capitalization 16.04B
Net income 2024 * 259M Net income 2025 * 364M EV / Sales 2024 * 8.48 x
Net cash position 2024 * 136M Net cash position 2025 * 380M EV / Sales 2025 * 6.31 x
P/E ratio 2024 *
62.5 x
P/E ratio 2025 *
44.6 x
Employees 765
Yield 2024 *
-
Yield 2025 *
-
Free-Float 44.8%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.61%
1 week-13.65%
Current month-16.98%
1 month-20.30%
3 months+32.41%
6 months+20.12%
Current year+26.27%
More quotes
1 week
67.53
Extreme 67.53
80.35
1 month
67.53
Extreme 67.53
95.63
Current year
49.46
Extreme 49.4604
99.62
1 year
29.75
Extreme 29.75
99.62
3 years
12.77
Extreme 12.77
99.62
5 years
1.02
Extreme 1.02
99.62
10 years
0.12
Extreme 0.1167
99.62
More quotes
Managers TitleAgeSince
Chief Executive Officer 44 11-12-31
Director of Finance/CFO 43 22-04-17
Investor Relations Contact - -
Members of the board TitleAgeSince
Director/Board Member 52 21-08-18
Director/Board Member 56 21-08-18
Director/Board Member 66 16-03-31
More insiders
Date Price Change Volume
24-04-19 68.84 -1.61% 3,574,788
24-04-18 69.97 -1.41% 3,301,200
24-04-17 70.97 -2.14% 3,973,529
24-04-16 72.52 -1.32% 4,097,694
24-04-15 73.49 -7.81% 5,562,735

Delayed Quote Nasdaq, April 19, 2024 at 04:00 pm EDT

More quotes
Celsius Holdings, Inc. is engaged in the development, processing, marketing, sale, and distribution of functional energy drinks to a range of consumers. The Company's flagship asset, CELSIUS, is marketed as a fitness drink or supplement which, with exercise, is designed to accelerate metabolism and burn body fat while providing energy. This product line comes in two versions: a ready-to-drink form and an on-the-go powder form. The Company also offers a new CELSIUS Essentials line, available in 16-ounce cans. Celsius products are offered in retail channels across the United States, including conventional grocery, natural, convenience, fitness, mass market, vitamin specialty and e-commerce. Additionally, the Company's products are also offered in certain Canadian, European, Middle Eastern and Asia-Pacific markets. Its product's formulation includes ingredients and supplements such as green tea (EGCG), ginger (from the root), calcium, chromium, B vitamins and vitamin C.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
68.84 USD
Average target price
92.92 USD
Spread / Average Target
+34.99%
Consensus